Highly Proliferative and Hypodifferentiated CAR-T Cells Targeting B7–H3 Enhance Antitumor Activity against Ovarian and Triple-Negative Breast Cancers

Researchers proposed a combination of elements for the construction of superior pluripotent CAR-T cells to provide an effective strategy for the treatment of intractable solid tumors.